Drug Proteomics
Pharmacoproteomics refers to the study of the proteomics of drugs, primarily used for the discovery of drug targets, drug target validation, and more. Biotech company Biotai Pike offers mass spectrometry-based pharmacoproteomics research services.
Pharmacoproteomics
Proteins are fundamental to various life activities, and studying proteins aids in understanding the mechanisms, diagnosis, and prevention of many diseases. Most drug targets are proteins, and proteomics has become increasingly important in drug development. Consequently, proteomics applied in drug development is termed pharmacoproteomics. Applications of pharmacoproteomics include screening new drug targets and studying drug mechanisms of action and adverse reactions.
Proteomics can be divided into expression proteomics and functional proteomics. Expression proteomics involves quantitative and qualitative analysis to study changes in protein expression, which can be used in drug development to screen disease-associated proteins and potential drug therapy targets, elucidating drug mechanisms and adverse reactions. Functional proteomics primarily studies protein interactions and how these interactions determine their functions. In drug research, it can confirm and validate drug targets by studying the interactions between target proteins and disease-related proteins.
Pharmacoproteomics
Main Techniques of Pharmacoproteomics
The main research techniques of pharmacoproteomics also include commonly used techniques in proteomics, such as two-dimensional gel electrophoresis (2DE) combined with mass spectrometry, LC-MS technology, label-based mass spectrometry techniques (such as SILAC), protein chip technology, and yeast two-hybrid technology.
Related Services
How to order?
